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acute exacerbations in the prior year. The ABSS showed
evidence of good internal consistency reliability (Cron-
bach’s alpha = 0.83), reproducibility (ICC = 0.67), and
construct validity (correlation with total SGRQ: r = 0.54,
p < 0.05). Among the subscales, correlation was highest
with the SGRQ Symptom subscale (r = 0.53, p < 0.05),
as expected. Discriminant validity was generally good
based on score spread across pulmonary function cate-
gories (mean score = 0.99 for mild, 1.22 for moderate,
and 1.38 for severe impairment). Psychometric results
were supported across the language versions.
CONCLUSIONS: The ABSS is a valid, reliable scale for
evaluating the symptoms associated with CB during the
stable phase away from an acute episode.
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OBJECTIVE: Back pain is a leading cause of absence and
disability in the workplace. Costs associated with losses
in productivity due to back pain are signiﬁcant and may
be as high as the costs of medical care for this condition.
However, there has been limited study of the indirect costs
of back pain in the United States. The objective of this
study was to determine the indirect costs due to back pain
in the U.S. population. 
METHODS: A retrospective analysis of the 1996 portion
of the Medical Expenditure Panel Survey (MEPS) was
conducted. The MEPS provided data from a nationally
representative sample of 22,601 respondents and data
from respondents’ medical care and health insurance
providers and employers. Data included medical condi-
tions and employment information comprised of hourly
earnings, hours worked, and disability days. Back pain
patients who incurred disability days were identiﬁed
using International Classiﬁcation of Diseases (ICD-9-
CM) codes determined by an expert panel of physicians
and coders as indicative of back pain and variables denot-
ing disability days. Indirect costs were calculated for back
pain patients who missed workdays using the human
capital approach. Sample estimates were weighted and
projected to the population and 95 percent conﬁdence
limits for estimates were calculated using the Taylor
expansion method.
RESULTS: Total indirect costs for back pain patients who
missed workdays were $18,533,583,620. Mean indirect
costs were $4,586 per back pain patient who missed
workdays (95% C.L. = $3,852 to $5,321). Relative to the
entire population, the mean indirect costs per person were
$68.92.
CONCLUSIONS: With losses in productivity greater
than $18.5 billion, indirect costs signiﬁcantly contribute
to the total costs of back pain. The indirect costs of back
pain to labor underscore the need to prevent back injury
thereby promoting employee health and maintaining 
productivity.
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Evidence based clinical practice guidelines (EBCPG) were
developed in response to combined direct and indirect
costs of low back pain (LBP) management approaching
approximately $100 billion annually in the US in the
early 1990s; but implementation of them has been slow.
Utilization of diagnostic imaging studies within the 
ﬁrst week of LBP uniformly exceeds all EBCPG 
recommendations.
OBJECTIVES: This investigation seeks to determine the
costs associated with private and HMO primary care, and
chiropractic utilization of diagnostic imaging studies 
conducted within the ﬁrst week of LBP diagnosis. 
METHODS: Systematic searches of Medline and other
databases were conducted, and identiﬁed studies were
reviewed according to inclusion criteria formulated 
from a base case. Medicare charges (2001) were used 
as surrogates of cost. Costs, utilities, and probabilities for
Markov modeling were based on systematic literature
review, database queries, and health care utilization
billing data. Monte Carlo simulation and sensitivity
analyses were performed with DATA Pro.
RESULTS: Of those patients whose symptoms resolved
within one week of diagnosis of LBP, 83%, 32%, 24%,
and 13% sought chiropractic, private family practice,
HMO primary care, and private internal medicine care,
respectively, received at least one diagnostic imaging
study. The difference in total cost between patients who
had an imaging study during their ﬁrst week of care and
those that did not, according to practice type, is $217.61,
$232.72, $229.59, $258.38 per week, respectively. 
CONCLUSION: All four practice settings’ initial utiliza-
tion exceeded that of the EBCPG’s recommended utiliza-
tion of diagnostic imaging studies within the ﬁrst week of
diagnosis of LBP (estimated 3%–4%); chiropractic use
was the most excessive, adding an estimated total cost 
to the system of $18,061.63 per every 100 patients com-
pared to $3358.94 for private internal medicine utiliza-
tion. EBPCG-based interventions to decrease chiropractic
use of imaging studies as diagnostic tools should be
emphasized and explored.
